Deal of the Day — limited-time pharmacy picks!
Bdenza 40mg capsule

Bdenza 40mg capsule

Salt Composition: Enzalutamide

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

28 Capsule(s) In A Strip

About The Product

Prostate Cancer


Bdenza 40 mg capsules are prescription drugs. The capsule contain active component, Enzalutamide, is an androgen receptor inhibitor that is categorized as an antineoplastic drug. It is recommended that only men use this capsule; women, particularly those who are carrying a baby, should not use it without gloves.

Uses

Advanced prostate cancer

Side Effects

  • It is advised to use Bdenza 40 mg capsule as directed by the doctor.
  • The common side effects of this tablet are: Trouble breathing (pneumonia) feeling tired Back pain diarrhoea cold headache insomnia high blood pressure swelling in arms, legs, feet, or hands

How To Use

  • Bdenza 40 mg capsules are not meant for self-medication; they should always be taken as directed by a physician.
  • As advised by the physician, it can be taken either with or without food.
  • Bdenza 40 mg capsule should not be chewed, opened, or crushed; it must be swallowed for the best efficiency of the drug.
  • It is an oral drug that is given once daily, before meals, at the same time every day.
  • One should wait for at least 3 hours before consuming the Bdenza 40 mg capsule.

How It Works

Bdenza 40 mg contains enzalutamide, which inhibits the androgen receptor. It prevents prostate cancer cells from being exposed to testosterone.

Cancer cell proliferation can be inhibited by preventing the production of testosterone, which helps in the growth of cancer cells. Bdenza 40 mg is an inhibitor of the androgen receptor.

Enzalutamide 40mg prevents signals from moving from the receptor to the cell, preventing cancer cells from functioning and slowing their growth.

Safety Advice

Alcohol
Drinking too much alcohol could damage a person's immunity and liver function. Alcohol consumption can cause dizziness, confusion, tiredness, and cognitive impairment, so it is advised not to consume alcohol while taking Bdenza 40 mg capsule.
Pregnancy
It is not advised to take the Bdenza 40 mg capsule when pregnant because it affects the fetus. This solution is not for use in women.
Breast Feeding
Because there is a possibility that the Bdenza 40 mg capsule could be transferred to the developing infant through the mother's breast milk, it is not advised to consume it while nursing. It is widely regarded as dangerous, and there is not enough evidence in the clinical data on its adverse impacts on infants.
Driving
Taking a Bdenza 40 mg capsule while operating machinery may cause confusion or impair one's driving capacity. The capsule may cause neurological side effects, such as fever or feeling dizzy. Until you feel better, don't drive.
Kidney
People with kidney issues can use the Bdenza 40mg capsule after consulting with the doctor. It may harm the kidneys if taken on self-medication.
Liver
People with severe liver illness should not use the Bdenza 40 mg capsule. Whereas people with mild liver disease can use this capsule, but it must be regularly monitored. Use caution and alter the dosage of the Bdenza 40 mg capsule as advised by your doctor.

FAQs

It is advised not to take alcohol while taking the Bdenza 40mg capsule, because consuming alcohol can cause serious side effects and can damage your liver badly.

Consult your doctor if you have concerns or queries.

Reference

Aggarwal, R., Halabi, S., Kelly, W. K., George, D., Mahoney, J.

F., Millard, F., & Alliance for Clinical Trials in Oncology. (2023).

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer: Results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401)(Alliance). Cancer, 119(20), 3636-3643.

Antonarakis, E. S.

(2025). Enzalutamide: the emperor of all anti-androgens.

Translational andrology and urology, 2(2), 119. Antonarakis, E.

S., Small, E. J., Petrylak, D.

P., Quinn, D. I., Kibel, A.

S., Chang, N. N., & Drake, C.

G. (2025).

Antigen-specific CD8 lytic phenotype induced by sipuleucel-T in hormone-sensitive or castration-resistant prostate cancer and association with overall survival. Clinical Cancer Research, 24(19), 4662-4671.

Attard, G., & Antonarakis, E. S.

(2024). AR aberrations and resistance to abiraterone or enzalutamide.

Nature Reviews Urology, 13(12), 697-698. Linder, S., van der Poel, H.

G., Bergman, A. M., Zwart, W., & Prekovic, S.

(2024). Enzalutamide therapy for advanced prostate cancer: efficacy, resistance, and beyond.

Endocrine-related cancer, 26(1), R31-R52.

Certified Content

Written By
Venika Choudhary

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By
Dr. Aditya Sarin

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026